Laekna-B (02105) Publishes Monthly Update on Share Capital and Equity Movements

Bulletin Express03-05

Laekna-B (02105) released its monthly equity issuer return for the period ended 28 February 2026, showing that the authorized share capital remains at 5.00 billion ordinary shares with a par value of US$0.00001 per share. This corresponds to a total authorized share capital of US$50,000, unchanged from the prior month.

The company’s total issued share capital stands at 446.47 million shares with no treasury shares, reflecting no increase or decrease during the month. The public float requirement remains satisfied under the relevant listing rules.

Regarding share option schemes, 24.76 million options under the Pre-IPO Share Option Scheme remain outstanding. The Post-IPO Share Option Scheme holds a potential capacity of 16.63 million shares, with no new issuances or exercises during this reporting period.

Under the 2024 Share Award Scheme, the mandate authorizes up to 39.01 million shares to be issued, with 3.90 million allocated to service providers. No new shares were issued or transferred out of treasury under this scheme in February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107428066?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 17:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107428066","market":"hk","top_or_hot":-1,"title":"Laekna-B (02105) Publishes Monthly Update on Share Capital and Equity Movements","media":"Bulletin Express","content":"<p>Laekna-B (02105) released its monthly equity issuer return for the period ended 28 February 2026, showing that the authorized share capital remains at 5.00 billion ordinary shares with a par value of US$0.00001 per share. This corresponds to a total authorized share capital of US$50,000, unchanged from the prior month.</p>\n<p>The company’s total issued share capital stands at 446.47 million shares with no treasury shares, reflecting no increase or decrease during the month. The public float requirement remains satisfied under the relevant listing rules.</p>\n<p>Regarding share option schemes, 24.76 million options under the Pre-IPO Share Option Scheme remain outstanding. The Post-IPO Share Option Scheme holds a potential capacity of 16.63 million shares, with no new issuances or exercises during this reporting period.</p>\n<p>Under the 2024 Share Award Scheme, the mandate authorizes up to 39.01 million shares to be issued, with 3.90 million allocated to service providers. No new shares were issued or transferred out of treasury under this scheme in February 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Laekna-B (02105) Publishes Monthly Update on Share Capital and Equity Movements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLaekna-B (02105) Publishes Monthly Update on Share Capital and Equity Movements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-05 17:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Laekna-B (02105) released its monthly equity issuer return for the period ended 28 February 2026, showing that the authorized share capital remains at 5.00 billion ordinary shares with a par value of US$0.00001 per share. This corresponds to a total authorized share capital of US$50,000, unchanged from the prior month.</p>\n<p>The company’s total issued share capital stands at 446.47 million shares with no treasury shares, reflecting no increase or decrease during the month. The public float requirement remains satisfied under the relevant listing rules.</p>\n<p>Regarding share option schemes, 24.76 million options under the Pre-IPO Share Option Scheme remain outstanding. The Post-IPO Share Option Scheme holds a potential capacity of 16.63 million shares, with no new issuances or exercises during this reporting period.</p>\n<p>Under the 2024 Share Award Scheme, the mandate authorizes up to 39.01 million shares to be issued, with 3.90 million allocated to service providers. No new shares were issued or transferred out of treasury under this scheme in February 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02105","symbol_name":"来凯医药-B","start_time":0,"source_url":"","article_id":"1107428066","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107428066","pubTimestamp":1772703311,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Laekna-B (02105) released its monthly equity issuer return for the period ended 28 February 2026, showing that the authorized share capital remains at 5.00 billion ordinary shares with a par value of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02105":"来凯医药-B"},"translate_title":"Laekna-B(02105)每月发布股本及权益变动更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02105":1},"content_text":"Laekna-B (02105) released its monthly equity issuer return for the period ended 28 February 2026, showing that the authorized share capital remains at 5.00 billion ordinary shares with a par value of US$0.00001 per share. This corresponds to a total authorized share capital of US$50,000, unchanged from the prior month.\nThe company’s total issued share capital stands at 446.47 million shares with no treasury shares, reflecting no increase or decrease during the month. The public float requirement remains satisfied under the relevant listing rules.\nRegarding share option schemes, 24.76 million options under the Pre-IPO Share Option Scheme remain outstanding. The Post-IPO Share Option Scheme holds a potential capacity of 16.63 million shares, with no new issuances or exercises during this reporting period.\nUnder the 2024 Share Award Scheme, the mandate authorizes up to 39.01 million shares to be issued, with 3.90 million allocated to service providers. No new shares were issued or transferred out of treasury under this scheme in February 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107428066","isCrawlerRequest":true}